Aspiriant LLC’s Schwab US Mid-Cap ETF SCHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$436K Hold
14,067
0.01% 234
2025
Q4
$423K Sell
14,067
-6,408
-31% -$191K 0.01% 234
2025
Q3
$607K Buy
20,475
+4,773
+30% +$139K 0.02% 188
2025
Q2
$440K Sell
15,702
-33,993
-68% -$897K 0.01% 212
2025
Q1
$1.3M Hold
49,695
0.05% 123
2024
Q4
$1.38M Buy
49,695
+2,448
+5% +$69.8K 0.05% 121
2024
Q3
$1.31M Sell
47,247
-246
-0.5% -$6.54K 0.05% 124
2024
Q2
$1.23M Buy
47,493
+912
+2% +$23.9K 0.05% 125
2024
Q1
$1.26M Sell
46,581
-159
-0.3% -$4.06K 0.05% 128
2023
Q4
$1.17M Sell
46,740
-2,361
-5% -$54.1K 0.05% 134
2023
Q3
$1.11M Sell
49,101
-84
-0.2% -$1.99K 0.06% 128
2023
Q2
$1.16M Sell
49,185
-3,243
-6% -$73.1K 0.06% 121
2023
Q1
$1.19M Buy
52,428
+84
+0.2% +$1.93K 0.06% 121
2022
Q4
$1.14M Hold
52,344
0.06% 119
2022
Q3
$1.06M Sell
52,344
-9
-0% -$201 0.05% 116
2022
Q2
$1.09M Sell
52,353
-900
-2% -$20.8K 0.05% 116
2022
Q1
$1.35M Sell
53,253
-1,671
-3% -$41.9K 0.07% 111
2021
Q4
$1.47M Sell
54,924
-1,605
-3% -$42.8K 0.08% 108
2021
Q3
$1.45M Sell
56,529
-717
-1% -$18.7K 0.08% 93
2021
Q2
$1.49M Sell
57,246
-306
-0.5% -$7.9K 0.08% 89
2021
Q1
$1.43M Sell
57,552
-2,544
-4% -$61.7K 0.09% 83
2020
Q4
$1.36M Sell
60,096
-2,376
-4% -$49.6K 0.09% 81
2020
Q3
$1.16M Sell
62,472
-1,653
-3% -$30.6K 0.09% 93
2020
Q2
$1.13M Sell
64,125
-42,306
-40% -$690K 0.1% 74
2020
Q1
$1.49M Sell
106,431
-21,438
-17% -$393K 0.15% 61
2019
Q4
$2.56M Sell
127,869
-2,604
-2% -$50.4K 0.24% 52
2019
Q3
$2.46M Sell
130,473
-17,700
-12% -$334K 0.22% 68
2019
Q2
$2.83M Sell
148,173
-14,907
-9% -$279K 0.24% 64
2019
Q1
$3.01M Sell
163,080
-41,313
-20% -$738K 0.25% 64
2018
Q4
$3.27M Sell
204,393
-36,696
-15% -$641K 0.25% 57
2018
Q3
$4.65M Sell
241,089
-30,591
-11% -$583K 0.4% 47
2018
Q2
$4.97M Sell
271,680
-41,796
-13% -$756K 0.43% 48
2018
Q1
$5.53M Buy
313,476
+270,822
+635% +$4.86M 0.48% 41
2017
Q4
$757K Sell
42,654
-468,276
-92% -$8.08M 0.22% 41
2017
Q3
$8.53M Sell
510,930
-103,677
-17% -$1.69M 0.72% 32
2017
Q2
$9.87M Sell
614,607
-109,005
-15% -$1.73M 0.86% 26
2017
Q1
$11.4M Sell
723,612
-38,928
-5% -$607K 0.97% 25
2016
Q4
$11.5M Buy
762,540
+229,530
+43% +$3.36M 1.04% 21
2016
Q3
$7.73M Buy
533,010
+13,674
+3% +$198K 0.77% 19
2016
Q2
$7.38M Sell
519,336
-109,890
-17% -$1.51M 0.7% 21
2016
Q1
$8.51M Buy
+629,226
New +$7.94M 0.81% 19

Other funds holding SCHM

Aspiriant LLC's SCHM Position: Q1 2026 in Review

Aspiriant LLC held its Schwab US Mid-Cap ETF (SCHM) position steady in Q1 2026 at 14,067 shares worth $436K. The position accounts for 0.01% of the portfolio, ranked #234.

Aspiriant LLC first reported a position in SCHM in Q1 2016 and has held it in 41 quarters since. The position peaked at $11.5M in Q4 2016. 1,010 funds tracked by Wall St. Rank hold SCHM as of Q1 2026.

  • Aspiriant LLC held 14,067 shares of Schwab US Mid-Cap ETF worth $436K as of Q1 2026.
  • Aspiriant LLC left its Schwab US Mid-Cap ETF share count unchanged in Q1 2026.
  • Schwab US Mid-Cap ETF made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #234 holding.
  • Aspiriant LLC first reported a position in Schwab US Mid-Cap ETF in Q1 2016 and has held it in 41 quarters since.
  • Aspiriant LLC's Schwab US Mid-Cap ETF position peaked at $11.5M in Q4 2016.
  • 1,010 funds tracked by Wall St. Rank held Schwab US Mid-Cap ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.